Literature DB >> 22762936

Nonpharmacologic approach to minimizing shivering during surface cooling: a proof of principle study.

Nirav G Shah1, Mark J Cowan, Edward Pickering, Houtan Sareh, Majid Afshar, Dawn Fox, Jennifer Marron, Jennifer Davis, Keith Herold, Carl B Shanholtz, Jeffrey D Hasday.   

Abstract

PURPOSE: This study had 2 objectives: (1) to quantify the metabolic response to physical cooling in febrile patients with systemic inflammatory response syndrome (SIRS) and (2) to provide proof for the hypothesis that the efficiency of external cooling and the subsequent shivering response are influenced by site and temperature of surface cooling pads.
METHODS: To quantify shivering thermogenesis during surface cooling for fever, we monitored oxygen consumption (VO(2)) in 6 febrile patients with SIRS during conventional cooling with cooling blankets and ice packs. To begin to determine how location and temperature of surface cooling influence shivering, we compared 5 cooling protocols for inducing mild hypothermia in 6 healthy volunteers.
RESULTS: In the patients with SIRS, core temperature decreased 0.67 °C per hour, all patients shivered, VO(2) increased 57.6%, and blood pressure increased 15% during cooling. In healthy subjects, cooling with the 10 °C vest was most comfortable and removed heat most efficiently without shivering or VO(2) increase. Cooling with combined vest and thigh pads stimulated the most shivering and highest VO(2) and increased core temperature. Reducing vest temperature from 10 °C to 5 °C failed to increase heat removal secondary to cutaneous vasoconstriction. Capsaicin, an agonist for the transient receptor potential cation channel subfamily V member 1 (TRPV1) warm-sensing channels, partially reversed this effect in 5 subjects.
CONCLUSIONS: Our results identify the hazards of surface cooling in febrile critically ill patients and support the concept that optimization of cooling pad temperature and position may improve cooling efficiency and reduce shivering.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22762936      PMCID: PMC3494806          DOI: 10.1016/j.jcrc.2012.04.016

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  52 in total

Review 1.  Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1.

Authors:  Narender R Gavva
Journal:  Trends Pharmacol Sci       Date:  2008-09-19       Impact factor: 14.819

2.  Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers.

Authors:  N M Graham; C J Burrell; R M Douglas; P Debelle; L Davies
Journal:  J Infect Dis       Date:  1990-12       Impact factor: 5.226

3.  Neuromuscular blockade in the intensive care unit.

Authors:  L C Gehr; C N Sessler
Journal:  Semin Respir Crit Care Med       Date:  2001       Impact factor: 3.119

4.  Gram-negative rod bacteremia. An analysis of 100 patients.

Authors:  U G Hodgin; J P Sanford
Journal:  Am J Med       Date:  1965-12       Impact factor: 4.965

5.  Achieving normothermia in patients with febrile subarachnoid hemorrhage: feasibility and safety of a novel intravascular cooling catheter.

Authors:  Neeraj Badjatia; Joan O'Donnell; John R Baker; David Huang; Cenk Ayata; David M Greer; Bob S Carter; Christopher S Ogilvy; Colin T McDonald
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

6.  Thresholds for thermal stimulation of the inner thigh, footpad, and face of cats.

Authors:  D R Kenshalo; D G Duncan; C Weymark
Journal:  J Comp Physiol Psychol       Date:  1967-02

7.  Measurement and prediction of peak shivering intensity in humans.

Authors:  D A Eyolfson; P Tikuisis; X Xu; G Weseen; G G Giesbrecht
Journal:  Eur J Appl Physiol       Date:  2001 Jan-Feb       Impact factor: 3.078

8.  The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group.

Authors:  G R Bernard; A P Wheeler; J A Russell; R Schein; W R Summer; K P Steinberg; W J Fulkerson; P E Wright; B W Christman; W D Dupont; S B Higgins; B B Swindell
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

9.  Hypothermia in the sepsis syndrome and clinical outcome. The Methylprednisolone Severe Sepsis Study Group.

Authors:  T P Clemmer; C J Fisher; R C Bone; G J Slotman; C A Metz; F O Thomas
Journal:  Crit Care Med       Date:  1992-10       Impact factor: 7.598

10.  Efficacy of and tolerance to mild induced hypothermia after out-of-hospital cardiac arrest using an endovascular cooling system.

Authors:  Nicolas Pichon; Jean Bernard Amiel; Bruno François; Anthony Dugard; Caroline Etchecopar; Philippe Vignon
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  3 in total

Review 1.  Hypothesis: Fever control, a niche for alpha-2 agonists in the setting of septic shock and severe acute respiratory distress syndrome?

Authors:  F Petitjeans; S Leroy; C Pichot; A Geloen; M Ghignone; L Quintin
Journal:  Temperature (Austin)       Date:  2018-05-22

2.  Pilot Feasibility Study of Therapeutic Hypothermia for Moderate to Severe Acute Respiratory Distress Syndrome.

Authors:  Donald F Slack; Douglas S Corwin; Nirav G Shah; Carl B Shanholtz; Avelino C Verceles; Giora Netzer; Kevin M Jones; Clayton H Brown; Michael L Terrin; Jeffrey D Hasday
Journal:  Crit Care Med       Date:  2017-07       Impact factor: 7.598

Review 3.  Should we treat pyrexia? And how do we do it?

Authors:  James F Doyle; Frédérique Schortgen
Journal:  Crit Care       Date:  2016-10-03       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.